federal_register: E7-23026
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E7-23026 | Behind the Counter Availability of Certain Drugs; Public Meeting; Comment Period Clarification | Notice | In the Federal Register of October 4, 2007 (72 FR 56769), the Food and Drug Administration (FDA) published a notice that announced a public meeting to obtain comments regarding behind-the-counter (BTC) availability of human drugs. An incorrect date was published in that notice. This document clarifies that Docket No. 2007N-0356 will close on December 17, 2007. | 2007-11-27 | 2007 | 11 | https://www.federalregister.gov/documents/2007/11/27/E7-23026/behind-the-counter-availability-of-certain-drugs-public-meeting-comment-period-clarification | https://www.govinfo.gov/content/pkg/FR-2007-11-27/pdf/E7-23026.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | In the Federal Register of October 4, 2007 (72 FR 56769), the Food and Drug Administration (FDA) published a notice that announced a public meeting to obtain comments regarding behind-the-counter (BTC) availability of human drugs. An incorrect date was... |